Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 31.00
+0.10 (0.32%)
Apr 29, 2026, 12:58 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 15.54 billion as of April 28, 2026. Its market cap has increased by 2.33% in one year.
Market Cap
15.54B
Enterprise Value
16.45B
Revenue
6.19B
Ranking
n/a
PE Ratio
18.61
Stock Price
31.00
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.54B, an increase of 2,562.62%. That is a compound annual growth rate of 17.85%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ScinoPharm Taiwan | 16.09B |
| YungShin Global Holding | 14.60B |
| Grape King Bio | 16.89B |
| TTY Biopharm Company | 17.93B |
| Foresee Pharmaceuticals | 12.84B |
| Handa Pharmaceuticals | 12.61B |
| Standard Chemical & Pharmaceutical | 10.94B |
| Alar Pharmaceuticals | 10.19B |